27 results
6-K
EX-99.1
SNY
Sanofi
1 Feb 24
Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline
9:45am
, by implementing an all-infant immunization policy, the emission of the current management of RSV infections in some countries could be reduced up
6-K
EX-99.1
SNY
Sanofi
27 Sep 23
Current report (foreign)
6:06am
, greenhouse gas emission had decreased 29% compared to 2019 in scopes 1 & 2 and by 7% in scope 3. In addition, the company has taken an end-to-end … for patients with atopic dermatitis showed reduced CO2 emission attributed to less frequent healthcare professionals’ visits while also improving patient
6-K
EX-99.1
SNY
Sanofi
28 Oct 22
Continued strong growth in Q3 with key regulatory milestones achieved
11:16am
inefficient traditional fuel cookstoves. By reducing fuelwood consumption by 60%, the project will avoid the emission of approximately 790ktCO2e
6-K
EX-99.1
SNY
Sanofi
28 Jul 22
Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
10:12am
.
Sanofi upgraded its scope 3 GHG emission reductions ambition to -30% by 2030, unveiling low energy intensity vaccines facility
Key milestone … environmental impacts including climate change delivers important progress, the company has decided to upgrade its greenhouse gas (GHG) emission
6-K
EX-99.3
4ic0zvgvnnfawytil
8 Jun 21
Sanofi launches its new global employee share ownership plan
1:31pm
424B3
nsaje lil
30 Mar 11
Prospectus supplement
12:00am
F-4/A
ry548w6yc8rb
18 Mar 11
Registration of securities (foreign) (amended)
12:00am
SC TO-T/A
EX-99
idm 9sxa3tynsvxkmv
16 Feb 11
Third party tender offer statement (amended)
12:00am